MDS study using detailed tests on blood and bone marrow
Part of Blood & lymphatic, Cancer clinical trials.
This study carefully evaluates people with myelodysplastic syndromes (MDS) and closely related blood disorders using detailed medical, blood, and bone marrow testing. The goal is to better understand these conditions and how they progress, which may help guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have (or might have) MDS or a related blood disorder like MDS/MPN, CMML, aCML, or MDS-related leukemia
- You may have had treatment already, and you can still join if you’re currently under MDS-focused care
- You have your own outside doctor (oncologist/hematologist/general doctor) who agrees to manage your care and results
- You can follow the study plan and be available for the full study period
- You (or your parent/guardian) can understand the study and sign consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study asks healthy adults to provide blood, bone marrow (if needed), skin, saliva, and stool samples. Scientists use these samples to compare patterns related to myeloid (bone-marrow) blood cancers, which may help future research and tests.
This study looks at special stem cells in the blood or bone marrow of people with myelodysplastic syndromes (MDS). It aims to better predict how the disease might progress and help guide treatment decisions.
This study checks whether a detailed blood-cell test can help diagnose myelodysplastic syndrome (MDS), a bone marrow condition that can cause low blood counts. Your results are compared with standard bone marrow testing to see how well the blood test performs.
This study looks at two childhood blood disorders—myelodysplastic syndromes (MDS) and juvenile myelomonocytic leukemia (JMML). The goal is to describe how these conditions work in children and better understand them over time.
This study collects information from people with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) that developed after cancer treatment. It does not test a new drug but helps doctors learn more about these conditions.
This trial collects and stores biological samples (like blood or other lab materials) from people with myelodysplastic syndrome, to help researchers learn more about the disease. It may help future diagnosis or treatments, even if it doesn’t directly test a new medicine.
Hear when a new Myelodysplastic Syndromes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.